Cefixime

Market Realities & Availability In The UK

Basic Cefixime Information

• INN (International Nonproprietary Name): not specified
• Brand Names Available In United Kingdom: not specified
• ATC Code: not specified
• Forms & Dosages: Film-coated tablets (various strengths); Effervescent/suspension (oral) such as 125mg/5ml, 250mg/5ml; Solutions for injection (ampoules/vials) and other forms where applicable.
• Manufacturers In United Kingdom: local manufacturers examples include Zentiva and multinational producers listed as examples in supplier lists; specific UK manufacturers for cefixime are not specified in the product-info section.
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription (Rx) in most regions; specific classification for individual cefixime products in the UK should be checked on the SmPC.

Worried about whether cefixime is on a local formulary or hard to source right now?

Cefixime is a niche but essential oral third‑generation cephalosporin used when first‑line agents are unsuitable.

Demand rises in the UK when nitrofurantoin or trimethoprim are unsuitable because of resistance or allergy.

Availability varies between NHS formularies, private clinics and online pharmacies.

Stock‑outs occur at times because of manufacturing bottlenecks or export demand pressures.

Reference to live pack sizes, strengths and supplier details should come from product pages using the product‑info section to show batch and manufacturer data.

For e‑commerce listings you should state prescription requirement, expected delivery times and NHS electronic prescription compatibility.

Common search concerns include cefixime availability UK, cefixime NHS and antibiotic shortages.

Supply Landscape And Demand Drivers

Who asks for cefixime most and why?

Clinicians request cefixime when community resistance or allergies make first‑line UTI agents unsuitable.

Private clinics and sexual health services also trigger demand, for example when alternative gonorrhoea therapies are indicated.

Manufacturing capacity and raw material supply chains from international producers influence availability.

Export demand to other markets can create temporary local shortages in the UK.

NHS formulary decisions and local microbiology susceptibility profiles drive prescribing patterns.

Online searches surge during local shortages or when primary care access is limited.

Keep an eye on public health resistance reports to anticipate demand spikes.

Pharmacy Channels And Stock Variability

Which outlets are likely to have cefixime in stock?

Retail chains, independent community pharmacies and registered online pharmacies all supply cefixime but their stock frequencies differ.

Scotland, Wales and Northern Ireland have prescription rules and free prescription schemes which affect patient cost and access.

Retail chains may dispense cefixime on NHS prescription or offer private supply depending on local policy.

Online pharmacies should show whether they accept NHS electronic prescriptions and expected dispatch times.

Below is a quick channel summary and a simple stock frequency table to help planning.

Real Patient Experiences & Common Use‑Cases

Patients often ask: What will cefixime actually do for my symptoms and how quickly will I feel better?

In practice cefixime is most commonly used for urinary tract infections when first‑line therapies are not suitable.

It is also used for some ENT infections and for resistant community infections where third‑generation coverage is required.

Once‑daily dosing for common formulations supports good adherence in many patients.

Common tolerability complaints are gastrointestinal upset and a metallic taste.

Typical patient pathways include prior antibiotic courses, urine or throat culture where available, and follow‑up if symptoms do not resolve.

Documenting anonymised outcomes helps product pages build trust and comply with E‑E‑A‑T expectations.

Typical Presenting Scenarios (UTI, ENT)

What do patients typically present with before cefixime is chosen?

For urinary tract infection cases a patient may have dysuria, frequency and suprapubic discomfort despite intolerance or resistance to nitrofurantoin.

For ENT infections cefixime is occasionally prescribed where wider Gram‑negative coverage is required.

Clinicians often wait for culture results when possible, or start empirical therapy if the patient is unwell or allergic to penicillins.

Symptom resolution timelines commonly seen are improvement within 48–72 hours for many UTIs when the pathogen is susceptible.

For product pages include guidance on expected response and when to return for review.

Adherence, Tolerability And Real‑World Feedback

How do patients report taking cefixime in the real world?

Adherence is generally good because many formulations are once‑daily.

Gastrointestinal side effects are the most frequently reported nuisance effect.

Allergic reactions are less common but must be documented and acted on if they occur.

Typical anonymised testimonial snippets help prospective patients understand likely outcomes.

• “Started feeling better in two days; mild nausea for a day.”
• “Once‑daily tablet was easy to take; bladder discomfort eased quickly.”

Patient guidance for pharmacy pages should state when to expect symptom relief and when to seek GP review.

Product Basics: INN, ATC And Common Formulations

Customers ask what form cefixime comes in and how it is classified.

Cefixime is the International Nonproprietary Name (INN) for this third‑generation cephalosporin.

The ATC classification commonly used for cefixime is J01DD08, which places it among systemic third‑generation cephalosporins.

Typical UK and European packs include oral tablets in 200 mg and 400 mg strengths, dispersible tablets and an oral suspension such as 50 mg/5 mL for children.

Some markets also carry 400 mg modified‑release or single‑dose regimens for selected indications.

Product pages must show exact strengths, excipients and pack counts and link to the BNF and SmPC for full information.

Product pages should include manufacturer, batch number and legal classification (Rx‑only) drawn from the product‑info section where available.

International Nonproprietary Name & Classification

The INN is cefixime and its ATC code is J01DD08.

That indicates systemic third‑generation cephalosporin antibacterial activity.

Use of the ATC code helps clinicians and pharmacists match formulary and interchange information.

Dosage Forms Commonly Stocked

Pharmacies commonly stock tablets, dispersible tablets and oral suspension suitable for paediatric dosing.

Product pages should declare excipients to support allergy checks and highlight if formulations are sugar‑free for diabetic patients.

Always cross‑check SmPC links for formulation‑specific advice on administration with or without food.

Licensed Indications & Regulatory Status (UK/EU)

People want to know what cefixime is licensed to treat and whether that applies in the UK.

Licence details can vary by product and by country, so always verify the SmPC and MHRA records for each brand.

Cefixime is licensed for several indications including some urinary tract infections and certain respiratory tract infections, and in some licences for gonorrhoea.

Exact licensed indications depend on the manufacturer licence in each market.

Off‑label use may be clinically appropriate in allergy‑sparing empirical therapy but should be justified and documented by the prescriber.

Include a regulatory block on product pages with MHRA/EMA references and licence number where available.

MHRA And EMA Approvals

Check the MHRA product licence and the EMA records for current approvals and any recent regulatory updates.

Pharmacists must not promote unlicensed indications as licensed uses without clear labelling.

Provide SmPC and PIL PDFs on product pages for prescribers and patients to consult.

Off‑Label Use And Prescribing Cautions

Prescribers commonly use cefixime off‑label in allergy cases while awaiting culture results.

Document the rationale for off‑label prescriptions and advise patients clearly about expected benefits and risks.

When promoting a specific product ensure the regulatory status statement is present and accurate on the product page.

Brands, Manufacturers & Packaging Variants

Shoppers often ask whether they will receive a branded supply or a generic pack.

The UK market is predominantly supplied by generic manufacturers with fewer branded products compared with some other drug classes.

Packaging varies from blister packs for tablets to bottles for suspensions and occasional sachets for dispersible doses.

Cross‑border e‑commerce should flag packaging language, excipients and local authorisation differences.

Product pages must populate brand tables with manufacturer, licence holder and country of origin from product‑info where available.

Major Brand Names And Generics In The UK

Branded cefixime options are less common than generics in the UK.

Pharmacies should show GTIN/serial numbers and pack images for customer reassurance.

International Packaging Differences To Note

Language on the packaging and excipient lists can differ between countries and affects suitability for some patients.

Always check manufacturer data on the product page before dispensing a cross‑border supply.

Dosage Guidance By Indication And Patient Group

Patients and prescribers need clear dosing guidance grouped by indication and patient characteristics.

Adults commonly receive 200–400 mg once daily or 400 mg twice daily depending on the indication and formulation.

Gonorrhoea regimens differ and rely on current public health guidance rather than standard UTI dosing.

Paediatric doses are weight‑based and commonly around 6–12 mg/kg per day depending on the SmPC and formulation used.

Renal impairment requires dose reductions or extended dosing intervals for creatinine clearance below recommended thresholds.

Adult Regimens For Common Infections

For most adults a once‑daily regimen is convenient and supports adherence.

Use local guidance for regionally recommended doses, particularly for community gonorrhoea management.

Paediatric And Renal/Hepatic Adjustments

State exact suspension concentration on the product page and provide weight‑based dosing calculators where possible.

Renal dose adjustments are required for reduced creatinine clearance and should reference the SmPC.

Contraindications, Cautions And Drug Interactions

People commonly ask whether cefixime is safe if they have penicillin allergy or take other medicines.

Absolute contraindication is known hypersensitivity to cefixime or other cephalosporins.

Caution is advised in patients with a history of severe immediate hypersensitivity to beta‑lactams due to cross‑reactivity risk.

Severe renal impairment and previous C. difficile infection are important cautions.

• Absolute Contraindications: Known hypersensitivity to cefixime or cephalosporins.
• Cautions: Severe penicillin allergy history, severe renal impairment.

Absolute Contraindications

Document any previous anaphylaxis to beta‑lactams and avoid cefixime in those cases.

Check excipients for known patient intolerances listed on the product page.

Notable Interactions To Highlight

Probenecid can raise plasma cefixime concentrations and should be considered when co‑prescribed.

Concurrent aminoglycosides increase the risk of nephrotoxicity and require monitoring.

Advise women of childbearing potential that some antibiotics may reduce contraceptive reliability and discuss barrier methods if concerned.

On product pages provide a clear interactions list and clinical actions such as “monitor”, “avoid” or “dose adjust”.

Side‑Effect Profile, Adverse Events & Monitoring

Patients commonly want to know what side effects are likely and when to seek help.

Common side effects include diarrhoea, nausea, abdominal pain and rash.

Less common but serious reactions include severe hypersensitivity, Stevens‑Johnson syndrome and cholestatic jaundice.

Clostridioides difficile colitis is a recognised risk with broad‑spectrum antibiotics and must be considered if diarrhoea persists.

Advise patients to stop the medicine and seek immediate care for breathing difficulties, facial swelling or severe skin reactions.

Pharmacists should consider baseline renal function for long or repeated courses in at‑risk patients.

Include Yellow Card reporting advice for suspected adverse reactions and provide MHRA reporting guidance on product pages.

Common And Less Common Adverse Effects

List common effects on the product page as diarrhoea and nausea, and highlight red‑flag reactions separately.

For persistent gastrointestinal symptoms advise medical review and consider C. difficile testing.

When To Seek Urgent Care And Reporting

Severe allergic signs or jaundice require urgent assessment and withdrawal of the drug.

Encourage patients and clinicians to report adverse events via the Yellow Card scheme and provide instructions on how to do so.

Pharmacology & Mechanism Of Action (Clinical Data)

Clinicians ask why cefixime is chosen over other agents from a microbiology perspective.

Cefixime is bactericidal and acts by inhibiting bacterial cell wall synthesis through binding penicillin‑binding proteins.

It has useful Gram‑negative activity including many Enterobacteriaceae and limited Gram‑positive coverage.

Rising resistance among E. coli and other Enterobacterales affects empirical UTI therapy decisions and underlines the need for local susceptibility data.

Stewardship principles recommend reserving cefixime for confirmed or strongly suspected pathogens unsuitable for narrower agents.

Product pages should link to local antimicrobial susceptibility tables or UKHSA reports where possible.

Antibacterial Spectrum And Clinical Relevance

The spectrum leans to Gram‑negative coverage which makes it useful in certain community infections when other options are inappropriate.

Always match the antibiotic spectrum to culture and sensitivity results when available.

Resistance Patterns And Stewardship Considerations

Document local resistance rates on product pages to help prescribers choose empiric therapy responsibly.

Avoid prolonging courses beyond recommended durations to limit resistance selection pressure.

Pharmacokinetics & Adjustments (Clinical Dosing Nuances)

Pharmacists often ask about bioavailability and how organ dysfunction affects dosing.

Oral cefixime has moderate bioavailability with variable absorption between formulations and with food.

It has a relatively long half‑life that allows once‑ or twice‑daily dosing depending on the regimen.

The drug is primarily renally excreted, so dose reductions or extended intervals are required in renal impairment.

Hepatic metabolism is limited so hepatic impairment less commonly needs adjustment, but monitor LFTs if indicated.

Absorption, Distribution And Elimination

Note Tmax and half‑life on the product SmPC and display these on product pages for prescribers.

Advise patients about possible variation in absorption with food for certain formulations.

Dose Modification In Organ Dysfunction

Provide concise renal dosing notes on the product page and link to the SmPC for exact CrCl thresholds.

Include pharmacist tips on switching formulations and counselling points about administration.

Storage, Handling, Transport & Stability

Patients frequently ask how to store suspensions and what to do with leftovers.

Follow the SmPC for product‑specific storage recommendations, commonly below 25°C and protected from moisture and light.

Unopened tablets are typically stable at ambient pharmacy temperatures.

Reconstituted suspensions commonly require refrigeration and have limited shelf‑life, often 7–14 days, depending on the product.

For online fulfilment ensure GDP‑compliant transport and packing to avoid exposure to high temperatures.

Include batch and expiry data on fulfilment slips for traceability.

Advise patients to shake suspensions well, to measure doses using the provided device and to dispose of leftovers safely.

Pharmacy Storage And Shelf‑Life

Keep a short SOP checklist in the dispensary for storage conditions and reconstitution instructions.

Display clear shelf‑life limits for reconstituted bottles on dispensing labels.

Patient Handling For Oral Suspensions

Show a simple reconstitution block on product pages and a visual reminder to refrigerate if required.

Stress use of supplied measuring devices to avoid dosing errors in children.

Dispensing, Labelling & Prescription Workflow (Pharmacy Practice)

Pharmacists must follow mandatory checks before handing over antibiotics.

Confirm indication, allergies, current medications and pregnancy status at the point of supply.

Record the reason for the antibiotic on the dispensing record and reconcile prescription duration with recommended course length.

Labelling must include dose, frequency, route, storage instructions and advice on completing the course.

For electronic prescriptions ensure brand and strength mapping is accurate and add a pharmacist note if an alternative brand is supplied.

Provide downloadable label templates and checklist items on the product page to speed safe dispensing.

Mandatory Prescription Checks And Documentation

Record the indication and verify that the supply matches the SmPC dosing for the patient group.

Document counselling and any supply of contraception advice if relevant.

Labelling And Patient Information Essentials

Include special storage notes such as “refrigerate after reconstitution” where applicable.

Attach a one‑page patient leaflet covering how to take the medicine and red‑flag symptoms.

Counselling Points & Patient Leaflets (Practical Use)

Patients want clear, practical advice on taking their medicine and recognising problems.

Key messages include completing the course unless advised otherwise and expectations for symptom improvement within 48–72 hours for many susceptible UTIs.

Advise on taking the medicine with or without food according to the SmPC and on likely GI side effects.

For women of childbearing potential discuss contraception reliability if relevant and advise to check with the prescriber about pregnancy and lactation safety.

Provide adherence aids such as dosing calendars and child‑friendly administration tips for suspensions.

Offer a downloadable one‑page leaflet and a short FAQ block on the product page including “Is cefixime safe in pregnancy?” and “How fast does cefixime work?”.

Key Messages For Patients

Tell patients to stop and seek urgent care for breathing difficulties or severe rash.

Remind patients that completing the full course reduces resistance risk.

Safety Netting And Adherence Aids

Provide a dosing calendar PDF and chewable/dispersible guidance for paediatric patients.

Link to NHS advice pages for further trusted information.

Competitors, Alternatives & Formulary Positioning

Clinicians and procurement teams ask when to choose cefixime versus other agents.

Alternatives for lower UTIs include nitrofurantoin and pivmecillinam where appropriate and susceptible.

For broader respiratory coverage amoxicillin/clavulanate may be considered, and for atypical pathogens azithromycin or doxycycline are options.

Cefixime is often a second‑line or allergy‑sparing option and should be used where narrower spectrum therapy is unsuitable.

Comparative Agents And When To Switch

Switch to narrower agents once culture and sensitivity results allow de‑escalation.

Document reasons for choosing cefixime on the clinical record for stewardship audits.

Cost, Efficacy And Stewardship Trade‑Offs

Show typical price bands and local formulary status on product pages to aid prescribers and procurement teams.

E‑Commerce Optimisation & Product Page Elements (Seo & Conversions)

What helps convert visitors to customers while maintaining compliance and trust?

Every product page should state legal classification (Rx only), provide SmPC and PIL links and show manufacturer and batch information from product‑info when available.

Include clear CTAs such as “Prescription required — upload RP” and trust signals like GPhC registration and MHRA links.

Optimise meta titles and descriptions for UK search intent and include product images, downloadable SmPC and a short FAQ block.

Use structured data/schema for medication to improve search listings and show delivery, prescription and NHS electronic prescription compatibility.

One natural purchase note for customers: In our online pharmacy, cefixime is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Required Product Content For Compliance And Trust

Include batch and expiry details on fulfilment slips and display storage and delivery caveats prominently.

Offer pharmacist contact details and a simple upload for prescriptions or a private prescriber service.

Seo Microcopy, Images And Schema Recommendations

Use long‑tail terms in titles such as “Cefixime 400 mg tablets — prescription antibiotic | UK pharmacy”.

Provide downloadable assets and a clear pricing table and CTA blocks to improve conversion.

Delivery Across United Kingdom

Final notes for site editors and pharmacists: Always pull manufacturer, batch and SmPC links directly from the product‑info section on the product page.

Where values in the product‑info are missing, mark them as not specified and advise users to contact the pharmacy for live availability.